Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,097,277
-$111,398 QoQ
Shares Held
45,568
+5.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,276
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellevest, Inc. holds $19,452,346 across 14 Drug Manufacturers - General names. PFE ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,180 | $3,814,187 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,926 | $3,074,491 | |
| 3 | JNJ |
Johnson & Johnson
|
50,449 | $2,009,847 | |
| 4 | NVS |
Novartis AG
|
12,495 | $1,958,216 | |
| 5 | AZN |
Astrazeneca PLC
|
6,725 | $1,275,194 | |
| 6 | PFE |
Pfizer Inc
This page
|
45,568 | $1,097,277 | |
| 7 | AMGN |
Amgen Inc
|
2,956 | $1,070,426 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,309 | $1,049,759 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,097,277 | 45,568 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,208,675 | 43,044 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $996,896 | 40,036 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,130,725 | 44,377 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,055,458 | 43,542 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $931,042 | 36,742 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $524,418 | 19,767 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $649,645 | 22,448 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $647,457 | 23,140 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $540,958 | 19,494 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $569,034 | 19,765 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $629,201 | 18,969 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $642,633 | 17,520 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $543,537 | 13,322 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $726,993 | 14,188 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $281,726 | 6,438 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $234,466 | 4,472 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $189,064 | 3,652 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $213,938 | 3,623 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $154,706 | 3,597 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $139,722 | 3,568 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $153,216 | 4,229 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $135,792 | 3,689 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $137,955 | 3,759 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $142,768 | 4,366 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $230,013 | 7,047 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||